-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U0Amo8EQChA+ffRXFI+uBbDiMakAPpoG3EArSNQoh+l8GVT84dovk33cUWnSwSp1 kAkmAEncJYN2Xsm9LnCkJA== 0000950133-02-003507.txt : 20021024 0000950133-02-003507.hdr.sgml : 20021024 20021024172848 ACCESSION NUMBER: 0000950133-02-003507 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-32142 FILM NUMBER: 02797774 BUSINESS ADDRESS: STREET 1: 8320 GUILFORD RD STREET 2: STE C CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 3078543900 MAIL ADDRESS: STREET 1: 8320 GUILFORD ROAD SUITE C STREET 2: 12111 PARKLAWN DR CITY: COLUMBIA STATE: MD ZIP: 21046 424B3 1 w63922e424b3.htm FILED PURSUANT TO RULE 424(B)(3) e424b3
 

Filed pursuant to Rule 424(b)(3)
File No. 333-32142

NOVAVAX, INC.

SUPPLEMENT NO. 1 DATED October 24, 2002
TO PROSPECTUS DATED January 14, 2002

     This Supplement contains information relating to the table under the caption “Selling Stockholders” in our January 14, 2002 prospectus.

     Mr. William E. Georges has transferred shares of our common stock to WEG Partners, L.P. As a result of this transaction, the disclosures concerning Selling Stockholders is updated by amending the information as to William E. Georges as Selling Stockholder and including WEG Partners, L.P. as follows:

                                         
    Shares Beneficially           Shares Beneficially
    Owned Prior to   Number of   Owned After
    Offering   Shares   Offering
Name of Selling Stockholder   Number   Percent   Being Offered   Number   Percent
 
 
 
 
 
William E. Georges (1)
     133,409          *       66,743       66,666       *  
WEG Partners, L.P.
     400,000       1.6       283,232       116,768       *  

(1)   William E. Georges is currently Senior Vice President of Fielding, a wholly owned subsidiary of Novavax. Includes 66,666 shares issuable to Mr. Georges pursuant to options exercisable within 60 days.

-----END PRIVACY-ENHANCED MESSAGE-----